MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clark, R. B.
Right arrow Articles by Strader, C. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clark, R. B.
Right arrow Articles by Strader, C. D.

Identification of a specific site required for rapid heterologous desensitization of the beta-adrenergic receptor by cAMP-dependent protein kinase

RB Clark, J Friedman, RA Dixon and CD Strader

Graduate School of Biomedical Sciences, University of Texas Health Science Center, Houston 77225.

The molecular basis for heterologous desensitization of the beta- adrenergic receptor (beta AR) was investigated by site-directed mutagenesis of the beta AR protein. Rapid heterologous desensitization of agonist-stimulated adenylyl cyclase activity was observed when L cells expressing the wild-type beta AR were incubated with 50 nM epinephrine. This desensitization response could be mimicked in a cell- free system by incubation with cAMP-dependent protein kinase (cA.PK). Deletion of amino acid residues 259-262 from the beta AR, removing one of the two consensus sequences in the receptor for phosphorylation by cA.PK, abolished the ability of the receptor to undergo rapid heterologous desensitization. In contrast, deletion of the other cA.PK consensus sequence (residues 343-348) or truncation of the Ser/Thr-rich C-terminal tail of the beta AR (deletion of residues 354-418) did not affect this heterologous desensitization process. These results suggest that the action of cA.PK on amino acid residue(s) contained within the sequence 259-262 of the beta AR is required for rapid heterologous desensitization of the receptor in response to agonists.

Volume 36, Issue 3, pp. 343-348, 09/01/1989
Copyright © 1989 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
CirculationHome page
S. Sanada, H. Asanuma, O. Tsukamoto, T. Minamino, K. Node, S. Takashima, T. Fukushima, A. Ogai, Y. Shinozaki, M. Fujita, et al.
Protein Kinase A as Another Mediator of Ischemic Preconditioning Independent of Protein Kinase C
Circulation, July 6, 2004; 110(1): 51 - 57.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
T. M. Tran, J. Friedman, E. Qunaibi, F. Baameur, R. H. Moore, and R. B. Clark
Characterization of Agonist Stimulation of cAMP-Dependent Protein Kinase and G Protein-Coupled Receptor Kinase Phosphorylation of the {beta}2-Adrenergic Receptor Using Phosphoserine-Specific Antibodies
Mol. Pharmacol., January 1, 2004; 65(1): 196 - 206.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. M. Willets, R. Mistry, S. R. Nahorski, and R. A. J. Challiss
Specificity of G Protein-Coupled Receptor Kinase 6-Mediated Phosphorylation and Regulation of Single-Cell M3 Muscarinic Acetylcholine Receptor Signaling
Mol. Pharmacol., November 1, 2003; 64(5): 1059 - 1068.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. T. Auman, F. J. Seidler, C. A. Tate, and T. A. Slotkin
Are developing beta -adrenoceptors able to desensitize? Acute and chronic effects of beta -agonists in neonatal heart and liver
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2002; 283(1): R205 - R217.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. M. Willets, R. A. J. Challiss, and S. R. Nahorski
Endogenous G Protein-coupled Receptor Kinase 6 Regulates M3 Muscarinic Acetylcholine Receptor Phosphorylation and Desensitization in Human SH-SY5Y Neuroblastoma Cells
J. Biol. Chem., May 3, 2002; 277(18): 15523 - 15529.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. N. Mason, L. B. Kozell, and K. A. Neve
Regulation of Dopamine D1 Receptor Trafficking by Protein Kinase A-Dependent Phosphorylation
Mol. Pharmacol., April 1, 2002; 61(4): 806 - 816.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. Wang, J. P. Herman, L. M. Pritchard, R. H. Spitzer, R. L. Ahlbrand, G. L. Kramer, F. Petty, F. R. Sallee, and N. M. Richtand
Cloning, Expression, and Regulation of a Glucocorticoid-Induced Receptor in Rat Brain: Effect of Repetitive Amphetamine
J. Neurosci., November 15, 2001; 21(22): 9027 - 9035.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. M. Willets, R. A. J. Challiss, E. Kelly, and S. R. Nahorski
G Protein-Coupled Receptor Kinases 3 and 6 Use Different Pathways to Desensitize the Endogenous M3 Muscarinic Acetylcholine Receptor in Human SH-SY5Y Cells
Mol. Pharmacol., August 1, 2001; 60(2): 321 - 330.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. A. Oliveira and T. E. Shenk
Murine cytomegalovirus M78 protein, a G protein-coupled receptor homologue, is a constituent of the virion and facilitates accumulation of immediate-early viral mRNA
PNAS, March 13, 2001; 98(6): 3237 - 3242.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Seibold, B. Williams, Z.-F. Huang, J. Friedman, R. H. Moore, B. J. Knoll, and R. B. Clark
Localization of the Sites Mediating Desensitization of the beta 2-Adrenergic Receptor by the GRK Pathway
Mol. Pharmacol., November 1, 2000; 58(5): 1162 - 1173.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
J. L. Zeiders, F. J. Seidler, and T. A. Slotkin
Agonist-Induced Sensitization of beta -Adrenoceptor Signaling in Neonatal Rat Heart: Expression and Catalytic Activity of Adenylyl Cyclase
J. Pharmacol. Exp. Ther., November 1, 1999; 291(2): 503 - 510.
[Abstract] [Full Text]


Home page
CirculationHome page
A. Lochner, S. Genade, E. Tromp, T. Podzuweit, and J. A. Moolman
Ischemic Preconditioning and the {beta}-Adrenergic Signal Transduction Pathway
Circulation, August 31, 1999; 100(9): 958 - 966.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. E. Limbird and D. E. Vaughan
Augmenting beta receptors in the heart: Short-term gains offset by long-term pains?
PNAS, June 22, 1999; 96(13): 7125 - 7127.
[Full Text] [PDF]


Home page
J. Immunol.Home page
B. Settmacher, D. Bock, H. Saad, S. Gartner, C. Rheinheimer, J. Kohl, W. Bautsch, and A. Klos
Modulation of C3a Activity: Internalization of the Human C3a Receptor and its Inhibition by C5a
J. Immunol., June 15, 1999; 162(12): 7409 - 7416.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Seibold, B. G. January, J. Friedman, R. W. Hipkin, and R. B. Clark
Desensitization of beta 2-Adrenergic Receptors with Mutations of the Proposed G Protein-coupled Receptor Kinase Phosphorylation Sites
J. Biol. Chem., March 27, 1998; 273(13): 7637 - 7642.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. January, A. Seibold, B. Whaley, R. W. Hipkin, D. Lin, A. Schonbrunn, R. Barber, and R. B. Clark
beta 2-Adrenergic Receptor Desensitization, Internalization, and Phosphorylation in Response to Full and Partial Agonists
J. Biol. Chem., September 19, 1997; 272(38): 23871 - 23879.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. J. Mundell, J. L. Benovic, and E. Kelly
A Dominant Negative Mutant of the G Protein-Coupled Receptor Kinase 2 Selectively Attenuates Adenosine A2 Receptor Desensitization
Mol. Pharmacol., June 1, 1997; 51(6): 991 - 998.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
S. Moffett, L. Adam, H. Bonin, T. P. Loisel, M. Bouvier, and B. Mouillac
Palmitoylated Cysteine 341Modulates Phosphorylation of the beta 2-Adrenergic Receptor by the cAMP-dependent Protein Kinase
J. Biol. Chem., August 30, 1996; 271(35): 21490 - 21497.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Jockers, A. D. Silva, A. D. Strosberg, M. Bouvier, and S. Marullo
New Molecular and Structural Determinants Involved in beta(2)-Adrenergic Receptor Desensitization and Sequestration
J. Biol. Chem., April 19, 1996; 271(16): 9355 - 9362.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. R. Post, O. Aguila-Buhain, and P. A. Insel
A Key Role for Protein Kinase A in Homologous Desensitization of the beta(2)-Adrenergic Receptor Pathway in S49 Lymphoma Cells
J. Biol. Chem., January 12, 1996; 271(2): 895 - 900.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. S. G. Ferguson, L. Ménard, L. S. Barak, W. J. Koch, A.-M. Colapietro, and M. G. Caron
Role of Phosphorylation in Agonist-promoted beta(2)-Adrenergic Receptor Sequestration
J. Biol. Chem., October 20, 1995; 270(42): 24782 - 24789.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Iwami, J.-i. Kawabe, T. Ebina, P. J. Cannon, C. J. Homcy, and Y. Ishikawa
Regulation of Adenylyl Cyclase by Protein Kinase A
J. Biol. Chem., May 26, 1995; 270(21): 12481 - 12484.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. M. Parker, P. Swigart, M. H. Nunnally, J. P. Perkins, and E. M. Ross
Carboxyl-terminal Domains in the Avian beta(1)-Adrenergic Receptor That Regulate Agonist-promoted Endocytosis
J. Biol. Chem., March 24, 1995; 270(12): 6482 - 6487.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. E. Brinson and T. K. Harden
Differential Regulation of the Uridine Nucleotide-activated P2Y4 and P2Y6 Receptors. SER-333 AND SER-334 IN THE CARBOXYL TERMINUS ARE INVOLVED IN AGONIST-DEPENDENT PHOSPHORYLATION DESENSITIZATION AND INTERNALIZATION OF THE P2Y4 RECEPTOR
J. Biol. Chem., April 6, 2001; 276(15): 11939 - 11948.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1989 by the American Society for Pharmacology and Experimental Therapeutics